Search

everythinglearnresearchcommunity

for

Search:↓

Discouragement regarding Pyrilutamide, a drug in development for hair loss, and the potential side effects of Finasteride. People discussed anecdotal experiences with Pyrilutamide as well as suggestions to wait out Phase 3 trials before making any conclusions.

OP switched from finasteride to dutasteride due to hair loss, but after 5 months, they are experiencing diffuse thinning and scalp issues. They are considering additional treatments like RU58841 and are using minoxidil, essential oils, and keto shampoo to manage symptoms.

The user is considering another hair transplant or scalp micropigmentation (SMP) for a congenital bald spot, but previous transplants were less effective due to scar tissue. Suggestions include using hair fibers, changing hairstyles, or doing nothing, as the spot is not very noticeable.

A user shared their successful hair regrowth journey using finasteride, minoxidil, microneedling, and castor oil, highlighting the importance of persistence despite initial shedding. They reported no side effects and encouraged consistency in treatment.

A 28-year-old male is experiencing hairline recession despite his family having full heads of hair. Suggested treatments include finasteride, minoxidil, and ketoconazole 2% shampoo.

Hair loss varies due to genetic sensitivity to DHT and other factors. Treatments discussed include finasteride, minoxidil, RU58841, and microneedling.

Hair regrowth can start as thin hairs that may thicken over time, with treatments like finasteride and minoxidil showing varied results. Some users report initial shedding followed by thicker regrowth, while others experience mixed outcomes in different areas.

Users are experiencing hair shedding after initial improvement using treatments like Minoxidil, finasteride, and dutasteride. Shedding is seen as a sign of progress, but concerns arise when hair falls out again after a few months.

A user expressed frustration with hair loss treatments, including finasteride, minoxidil with micro-needling, and RU58841, which all failed to stop hair thinning and miniaturization. Suggestions from others included accepting baldness, considering hair systems, and continuing prescribed antidepressants for depression.

A 27-year-old male with diffuse hair loss, including the donor area, did not respond to finasteride, dutasteride, or minoxidil. He suspects his hair loss may be linked to a mild connective tissue disorder, possibly affecting the structural support of hair follicles, rather than being purely hormonal.

A user's hairline recovery after severe hair loss, which was treated with Dutasteride and Minoxidil; other users offered their opinions on the severity of the hair loss.

Temporal peaks are crucial for a natural-looking hair transplant, but they are challenging to achieve due to the need for precise angles and appropriate hair thickness. Many users emphasize the importance of finding a skilled surgeon and using finasteride to maintain hairline stability.

A 39-year-old user experienced hair regrowth using oral dutasteride, oral minoxidil, dermastamping, and Nizoral shampoo after switching from finasteride and topical minoxidil. They are hopeful for significant improvement in their receding hairline.

A 24-year-old male experienced hair loss regression after 3.5 years on topical finasteride and minoxidil. He is considering switching to topical dutasteride or oral finasteride due to concerns about side effects and is seeking advice on the efficacy of these treatments.

The Phase 2 trial for Pyrilutamide in the US, which started a year after the China trials, and inquiring about any available information on when it will finish. Treatments discussed include Minoxidil, Finasteride, and RU58841.

The conversation discusses various hair loss treatments, including Breezula, KX826, and PP405, with mixed opinions on their effectiveness compared to finasteride and minoxidil. Some users express skepticism about the new treatments, while others remain hopeful about future developments.

The conversation discusses the potential use of verteporfin for hair loss treatment, with one user mentioning their surgeon's interest in trying it and another noting its research status and clinical use as a YAP inhibitor. Some users debate the market size, availability of generics, and the optimism in the hair loss community regarding new treatments.

A new hair loss treatment, PP405, showed promising Phase 2a results with 31% of patients experiencing over 20% hair density increase without systemic absorption, avoiding hormonal side effects. The treatment is expected to be expensive, with Phase 3 trials starting mid-2026, and there is skepticism about the data's strength.

A user shared a 6-month hair regrowth journey using topical Minoxidil, oral Finasteride, and Nizoral, noting increased hair density and color. They apply treatments once daily before bed and have experienced a second shedding phase, which they believe is normal.

The conversation discusses hair loss treatments, specifically the use of minoxidil, finasteride, and microneedling, and the experience of shedding hair as a potential sign of treatment effectiveness. Some users report positive results after initial shedding, while others express concerns about long-term hair loss and the effectiveness of treatments.

The user is experiencing slow but solid hair regrowth using topical finasteride, oral minoxidil, keto shampoo, microneedling, RU58841, and rosemary oil. Another user suggests being grateful for the dense coverage.

The user experienced severe hair shedding from months 10 to 14 but saw significant hair regrowth after continuing treatment with 1.2 mg finasteride and 3 mg minoxidil. They advise not to give up on medication despite initial setbacks.

A human trial of verteporfin, a drug that can inhibit wound healing by scarring and promote regeneration of original tissue and hair follicles to provide an unlimited source for hair transplants; people discussed the potential of this drug and how it could be rolled out in mainstream with more doctors getting on board.

PP405 may revive dormant hair follicles but is unlikely to help with long-term baldness where follicles are replaced by scar tissue. It is seen as a potential adjunct to treatments like minoxidil and finasteride, but its effectiveness on deeply fibrotic or scarred areas is doubtful.

The conversation discusses using RU58841 or Pyrilutamide for hair loss, with some users suggesting switching to more proven treatments like oral or topical finasteride. One user reports no progress with RU58841, finasteride, and minoxidil, and mentions experiencing regression.

Genetic differences in hair follicles affect hair loss patterns. Treatments discussed include finasteride, dutasteride, minoxidil, and RU58841.

The user is using a regimen including topical finasteride, ketoconazole, melatonin, keto shampoo, pyrilutamide, microneedling, and tretinoin for hair loss, and is considering switching to oral finasteride for convenience and potentially better results. Some users suggest switching to oral finasteride and checking for health issues like nutrient absorption, while others note maintenance or slight improvement in hair thickness.

Replicel's results were delayed, but Shiseido might share data at BioJapan on October 11. Users are hopeful for new treatments like RCH-01, potentially eliminating the need for finasteride or minoxidil.

Hair loss recovery using estrogen and anti-androgen treatment for 18 months showed significant improvement. However, results vary and alternative treatments like RU58841 and Dutasteride may work without systemic feminization.

A user has been experiencing hair loss for 4 years, with treatments like minoxidil, finasteride, and various supplements proving ineffective. They were diagnosed with fibrosing alopecia in a pattern distribution, a condition that may require a combination of anti-inflammatory and hair growth treatments.